Richwood Investment Advisors LLC lowered its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 2.5% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,136 shares of the financial services provider’s stock after selling 182 shares during the quarter. Richwood Investment Advisors LLC’s holdings in Aflac were worth $798,000 at the end of the most recent quarter.
A number of other large investors also recently bought and sold shares of the company. Y.D. More Investments Ltd acquired a new stake in shares of Aflac during the 2nd quarter valued at approximately $25,000. Atwood & Palmer Inc. increased its stake in Aflac by 80.0% during the first quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 140 shares during the last quarter. OFI Invest Asset Management acquired a new stake in shares of Aflac during the first quarter worth $29,000. Dixon Mitchell Investment Counsel Inc. bought a new position in shares of Aflac in the 1st quarter worth about $34,000. Finally, Cedar Wealth Management LLC acquired a new position in shares of Aflac in the 1st quarter valued at about $50,000. Institutional investors own 67.44% of the company’s stock.
Aflac Price Performance
Shares of AFL stock traded up $0.37 during midday trading on Tuesday, reaching $114.44. 262,171 shares of the company were exchanged, compared to its average volume of 2,234,335. The company’s 50 day moving average price is $108.24 and its two-hundred day moving average price is $95.16. The company has a market cap of $65.03 billion, a P/E ratio of 12.59, a PEG ratio of 2.62 and a beta of 0.95. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10.
Aflac Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.75%. Aflac’s dividend payout ratio (DPR) is 22.08%.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on AFL shares. Piper Sandler increased their price objective on shares of Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Barclays began coverage on Aflac in a research report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price target on the stock. Jefferies Financial Group reduced their price objective on Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Truist Financial upped their price objective on Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Finally, Bank of America raised their target price on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Aflac currently has a consensus rating of “Hold” and an average price target of $97.53.
Read Our Latest Research Report on AFL
Insider Activity at Aflac
In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now directly owns 18,158 shares in the company, valued at approximately $1,796,552.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.90% of the company’s stock.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- CD Calculator: Certificate of Deposit Calculator
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
- Using the MarketBeat Dividend Tax Calculator
- Seize the Opportunity: 2 High-Yield Stocks for Your Portfolio
- How to Invest in Biotech Stocks
- 3 Stocks Investors Don’t Want to Miss Ahead of Earnings
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.